Tobacco Control 2006;15:417-418; doi:10.1136/tc.2006.018887
Copyright © 2006 by the BMJ Publishing Group Ltd.
Clinical trial registration at Tobacco Control
L A Bero
Correspondence to:
Professor Lisa A Bero
Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco, CA 94143-0936, USA; berol@pharmacy.ucsf.edu
Submissions to Tobacco Controlthe "ins" and "outs"
| The first 150 words of the full text of this article appear below. |
Tobacco Control publishes systematic reviews, meta-analyses and clinical trials. The complete and accurate reporting of these trials is crucial to establish the scientific evidence on which sound clinical decisions can be based. Systematic reviews and meta-analyses of randomised controlled trials are the most methodologically rigorous types of evidence to evaluate the effectiveness of therapeutic interventions, particularly pharmacotherapy.1,2 They often form the foundation for practice guidelines, clinical decision support systems, drug formulary decisions and drug payment schemes. However, systematic reviews proceed under the assumption that a complete and representative sample of relevant studies is available for analysis.3 As access to relevant studies is often limited to published studies, systematic reviews and meta-analyses, and, ultimately, practice guidelines and patient care, are particularly vulnerable to biases that may affect publication.
"SCIENTIFIC MISCONDUCT"
One type of publication biasthe publication of study results based on the direction and statistical significance of study findingsposes a . . . [Full text of this article]
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.